Once this technology becomes available, it would be able to separate subpopulations presenting high activity or expression of both ALDH1 and SOX2 and could potentially represent tumor-propagating subpopulations better than the cell subset solely selected by ALDH1 activity. This evidence concerns the gene SOX2 and neoplasm.